Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00723255 · COMPLETED

Trial details

NCT number: NCT00723255
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Endometrial Carcinoma

Start date: 2008-09-01
Primary completion: 2011-07-15
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.